MAEDA HITOSHI 前田仁志

… Alternative Names

Hitoshi Maeda 前田仁志

Less

Researcher Number	80791483
Other IDs
Affiliation (Current)	2023: 熊本大学, 大学院生命科学研究部(薬), 助教
Affiliation (based on the past Project Information) *help	2019 – 2021: 熊本大学, 大学院生命科学研究部(薬), 助教 2017 – 2019: 熊本大学, 薬学部, 助教
Review Section/Research Field	Principal Investigator Medical pharmacy / Basic Section 47060:Clinical pharmacy-related Except Principal Investigator Basic Section 48030:Pharmacology-related / Medium-sized Section 47:Pharmaceutical sciences and related fields
Keywords	Principal Investigator マクロファージ / 線維芽細胞 / アルブミン / 腫瘍関連マクロファージ / 癌関連線維芽細胞 / がん微小環境 / 腫瘍間質 / ポリエチレングリコール / ドラッグデリバリーシステム / 薬学 / 癌細胞 / 遺伝子工学技術 … More Except Principal Investigator … More バイオミメティック / アルブミン融合技術 / アルブミン / 一酸化炭素 / 赤血球 / 細胞療法 / 急性腎障害 / COデリバリーシステム / 横紋筋融解症 / アルブミン創薬プラットフォーム / 災害医療 / ヘムオキシゲナーセ-1 / サルコペニア / 健康寿命 / ミオスタチン / ドラッグデリバリーシステム / 筋萎縮因子 / チオレドキシン / グレリン / sActRIIB / バイオミメティクDDS Less

癌細胞-癌微小環境ネットワークを狙い撃つ革新的な抗癌剤送達システムの開発Principal Investigator
- Principal Investigator
  
  前田仁志
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Kumamoto University
Development of Biomimetic DDS to improve healthy longevity and its application to the treatment for sarcopenia
- Principal Investigator
  
  Maruyama Toru
- Project Period (FY)
  2020 – 2021
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 47:Pharmaceutical sciences and related fields
- Research Institution
  Kumamoto University
Development of a renal carbon monoxide delivery system for treatment of lethal rhabdomyolysis
- Principal Investigator
  
  Maruyama Toru
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 48030:Pharmacology-related
- Research Institution
  Kumamoto University
Development of innovative drug delivery carrier targeting tumor microenvironment and application for intractable cancerPrincipal Investigator
- Principal Investigator
  
  Hitoshi Maeda
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kumamoto University

All 2021 2020 2019 2018 2017

All Journal Article Presentation

[Journal Article] A Mannosylated, PEGylated Albumin as a Drug Delivery System for the Treatment of Cancer Stroma Cells2021
- Author(s)
  Mizuta Y, Maeda H, Ishima T, Minayoshi Y, Ichimizu S, Kinoshita R, Fujita I, Kai T, Hirata H, Nakamura T, Saruwari J, Arima H, Watanabe H, Otagiri M, Maruyama T
- Journal Title
  
  Advanced Functional Materials
  
  Volume: 31 Pages: 2104136-2104136
- DOI
  10.1002/adfm.202104136
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K06810, KAKENHI-PROJECT-19J23629, KAKENHI-PROJECT-21K06514, KAKENHI-PROJECT-21K15315
[Journal Article] An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action2021
- Author(s)
  Hiroshi Watanabe*,#, Rui Fujimura*, Yuto Hiramoto*, Ryota Murata, Kento Nishida, Jing Bi, Tadashi Imafuku, Hisakazu Komori, Hitoshi Maeda, Ayumi Mukunoki, Toru Takeo, Naomi Nakagata, Motoko Tanaka, Kazutaka Matsushita, Masafumi Fukagawa, Toru Maruyama# *equal contribution; #equal correspondence
- Journal Title
  
  Sci Rep
  
  Volume: 12;11(1) Pages: 7953-7953
- DOI
  10.1038/s41598-021-87217-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02604, KAKENHI-PROJECT-18J23070, KAKENHI-PROJECT-20K21485, KAKENHI-PROJECT-21K19340
[Journal Article] Effects of Uremic Toxins on the Binding of Aripiprazole to Human Serum Albumin2021
- Author(s)
  Koji Nishi, Keiki Sakurama, Hiroshi Watanabe, Toru Maruyama, Keishi Yamasaki, Masaki Otagiri
- Journal Title
  
  Biol. Pharm. Bull.
  
  Volume: 44(3) Issue: 3 Pages: 1583-1590
- DOI
  10.1248/bpb.b20-00929
- NAID
  130007993459
- ISSN
  0918-6158, 1347-5215
- Year and Date
  2021-03-01
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K21485, KAKENHI-PROJECT-18H02604
[Journal Article] A synthetic retinoic acid receptor agonist Am80 ameliorates renal fibrosis via inducing the production of alpha-1-acid glycoprotein2020
- Author(s)
  Imafuku, T., Watanabe, H., Satoh, T., Matsuzaka, T., Inazumi, T., Kato, H., Tanaka, S., Nakamura, Y., Nakano, T., Tokumaru, K., Maeda, H., Tanaka, M., Matsushita, K., Tsuchiya, S., Sugimoto, Y., Shimano, H., Fukagawa, M., and Maruyama, T.
- Journal Title
  
  Sci Rep
  
  Volume: 1 Pages: 11424-11424
- DOI
  10.34067/kid.0000772019
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K22503, KAKENHI-PROJECT-20K21485, KAKENHI-PROJECT-17H03990, KAKENHI-PROJECT-18H02604, KAKENHI-PROJECT-20H03406, KAKENHI-PROJECT-18K14904
[Journal Article] Effect of Cinacalcet on the Redox Status of Albumin in Secondary Hyperparathyroidism Patients Receiving Hemodialysis2020
- Author(s)
  Imafuku Tadashi、Tanaka Motoko、Tokunaga Koki、Miyamura Shigeyuki、Kato Hiromasa、Tanaka Shoma、Nakano Takehiro、Hirata Kenshiro、Kadowaki Daisuke、Maeda Hitoshi、Matsushita Kazutaka、Otagiri Masaki、Komaba Hirotaka、Fukagawa Masafumi、Watanabe Hiroshi、Maruyama Toru
- Journal Title
  
  Biol. Pharm. Bull.
  
  Volume: 43 Issue: 10 Pages: 1583-1590
- DOI
  10.1248/bpb.b20-00472
- NAID
  130007920876
- ISSN
  0918-6158, 1347-5215
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06810, KAKENHI-PROJECT-20K21485, KAKENHI-PROJECT-18H02604, KAKENHI-PROJECT-20H03406, KAKENHI-PROJECT-18K06774
[Journal Article] The late-stage protective effect of Mito-TEMPO against acetaminophen-induced hepatotoxicity in mouse and three-dimensional cell culture models2020
- Author(s)
  Yamasaki Keishi、Sakurama Keiki、Nishi Koji、Watanabe Hiroshi、Maruyama Toru、Seo Hakaru、Otagiri Masaki、Taguchi Kazuaki
- Journal Title
  
  Antioxidants (Basel)
  
  Volume: 109 Pages: 2919-2924
- DOI
  10.1016/j.xphs.2020.06.011
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06810, KAKENHI-PROJECT-20K21485, KAKENHI-PROJECT-18H02604
[Journal Article] alfa1-acid glycoprotein attenuates adriamycin-induced nephropathy via CD163 expressing macrophages induction.2020
- Author(s)
  Fujimura Rui、Watanabe Hiroshi、Nishida Kento、Fujiwara Yukio、Koga Tomoaki、Bi Jing、Imafuku Tadashi、Kobayashi Kazuki、Komori Hisakazu、Miyahisa Masako、Maeda Hitoshi、Tanaka Motoko、Matsushita Kazutaka、Wada Takashi、Fukagawa Masafumi、Maruyama Toru
- Journal Title
  
  Sci Rep
  
  Volume: ー Pages: 343-353
- DOI
  10.34067/kid.0000782019
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18J23070, KAKENHI-PROJECT-17K08664, KAKENHI-PROJECT-20K21485, KAKENHI-PROJECT-18H02604
[Journal Article] A synthetic retinoic acid receptor agonist Am80 ameliorates renal fibrosis via inducing the production of alpha-1-acid glycoprotein.2020
- Author(s)
  Watanabe Hiroshi、Bi Jing、Murata Ryota、Fujimura Rui、Nishida Kento、Imafuku Tadashi、Nakamura Yuka、Maeda Hitoshi、Mukunoki Ayumi、Takeo Toru、Nakagata Naomi、Kurauchi Yuki、Katsuki Hiroshi、Tanaka Motoko、Matsushita Kazutaka、Fukagawa Masafumi、Maruyama Toru
- Journal Title
  
  J Control Release
  
  Volume: 10 Pages: 11424-11424
- DOI
  10.1038/s41598-020-68337-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07101, KAKENHI-PROJECT-19K22813, KAKENHI-PROJECT-20K21485, KAKENHI-PROJECT-18H02604, KAKENHI-PROJECT-20H04126
[Journal Article] Indoxyl sulfate contributes to adipose tissue inflammation through the activation of NADPH oxidase2020
- Author(s)
  Hiroshi Watanabe*,#, Masako Miyahisa*, Mayuko Chikamatsu*, Kento Nishida, Yuki Minayoshi, Mei Takano, Shota Ichimizu, Yoshihiro Kobashigawa, Hiroshi Morioka, Hitoshi Maeda, Toru Maruyama# *equal contribution; #equal correspondence
- Journal Title
  
  Toxins (Basel)
  
  Volume: 10;324: Pages: 502-502
- DOI
  10.1016/j.jconrel.2020.05.036
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K21485, KAKENHI-PROJECT-18H02604
[Journal Article] Drug delivery system for refractory cancer therapy via an endogenous albumin transport system2020
- Author(s)
  Kento Nishida*, Hiroshi Watanabe*,#, Masako Miyahisa, Yuto Hiramoto, Hiroto Nosaki, Rui Fujimura, Hitoshi Maeda, Masaki Otagiri, Toru Maruyama# *equal contribution; #equal correspondence
- Journal Title
  
  Chem Pharm Bull (Tokyo)
  
  Volume: 26;10(1): Pages: 20635-20635
- DOI
  10.1038/s41598-020-75025-5
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K21485, KAKENHI-PROJECT-18H02604
[Journal Article] The late-stage protective effect of Mito-TEMPO against acetaminophen-induced hepatotoxicity in mouse and three-dimensional cell culture models2020
- Author(s)
  Abdullah-Al-Shoeb Mohammad、Sasaki Kenta、Kikutani Saori、Namba Nanami、Ueno Keiichi、Kondo Yuki、Maeda Hitoshi、Maruyama Toru、Irie Tetsumi、Ishitsuka Yoichi
- Journal Title
  
  Sci Rep
  
  Volume: 9 Pages: 20635-20635
- DOI
  10.3390/antiox9100965
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K07066, KAKENHI-PROJECT-20K21485, KAKENHI-PROJECT-18H02604
[Journal Article] Characterization of the Interaction of Daptomycin With Site II on Human Serum Albumin2020
- Author(s)
  Shoma Tanaka*, Hiroshi Watanabe*,#, Takehiro Nakano, Tadashi Imafuku, Hiromasa Kato, Kai Tokumaru, Nanaka Arimura, Yuki Enoki, Hitoshi Maeda, Motoko Tanaka, Kazutaka Matsushita, Masafumi Fukagawa, Toru Maruyama# *equal contribution; #equal correspondence
- Journal Title
  
  Toxins
  
  Volume: 5;12(8): Pages: 2919-2924
- DOI
  10.3390/toxins12080502
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K21485, KAKENHI-PROJECT-18H02604, KAKENHI-PROJECT-20H03406, KAKENHI-PROJECT-18K15069
[Presentation] がん間質細胞を標的とするDDS担体の開発2021
- Author(s)
  ○前田仁志、水田夕稀、異島優、渡邊博志、小田切優樹、丸山徹
- Organizer
  第28回日本血液代替物学会年次大会
- Invited
- Data Source
  KAKENHI-PROJECT-21K15315
[Presentation] がん間質細胞を二重標的化する抗がん剤送達キャリアの開発と新規がんDDS戦略の構築2021
- Author(s)
  ○水田夕稀、前田仁志、皆吉勇紀、一水翔太、木下遼、異島優、渡邊博志、小田切優樹、丸山徹
- Organizer
  第37回日本DDS学会学術集会
- Data Source
  KAKENHI-PROJECT-21K15315
[Presentation] A bioinspired albumin as a versatile active targeting tool for macrophage and fibroblast2021
- Author(s)
  ○Hitoshi Maeda
- Organizer
  APSTJ Global Education Seminar 2021-2nd
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K15315
[Presentation] がん間質細胞を二重標的化する抗がん剤デリバリーシステムの構築2021
- Author(s)
  ○水田夕稀、前田仁志、皆吉勇紀、一水翔太、木下遼、異島優、渡邊博志、小田切優樹、丸山徹
- Organizer
  日本薬剤学会超分子薬剤学FG　第２回オンラインシンポジウム
- Data Source
  KAKENHI-PROJECT-21K15315
[Presentation] Development of Kupffer cell targeting nano-antioxidant as a novel therapeutic strategy for nonalcoholic steatohepatitis2019
- Author(s)
  Hitoshi Maeda, Toru Maruyama
- Organizer
  第27回韓国応用薬学会
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] Development of a novel tumor microenvironment-targeted drug deliver carrier；TAMとCAFを包括的に標的化する抗がん剤デリバリーシステムの構築2019
- Author(s)
  水田夕稀、前田仁志、皆吉勇紀、一水翔太、木下遼、異島優、渡邊博志、小田切優樹、馬場秀夫、丸山徹
- Organizer
  第30回日本消化器癌発生学会総会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] がん微小環境を治療標的とするDual targeting 担体の開発と新規がんDDS戦略の構築2019
- Author(s)
  水田　夕稀、前田仁志、皆吉　勇紀、一水　翔太、木下　遼、異島　優、渡邊　博志、小田切　優樹、丸山徹
- Organizer
  日本薬剤学会第34年会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] がん微小環境を二重標的化する抗がん剤送達キャリアの開発2019
- Author(s)
  水田夕稀、前田仁志、皆吉勇紀、一水翔太、木下遼、異島優、渡邊博志、小田切優樹、丸山徹
- Organizer
  第44回製剤・創剤セミナー
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] Co-treatment of EPR enhancer increases the anti-tumor effect of nab-paclitaxel against pancreatic cancer；EPR増強剤の併用は膵臓癌に対するnab-パクリタキセルの治療効果を増強する2019
- Author(s)
  丸山徹、木下遼、前田仁志、渡邊博志、小田切優樹、異島優
- Organizer
  第30回　日本消化器癌発生学会総会
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18H02604
[Presentation] Albumin based nitric oxide delivery system ameliorates the kidney fibrosis in unilateral ureteral obstruction-treated mice2018
- Author(s)
  Shun Oshiro, Yu Ishima, Hitoshi Maeda, Hiroshi Watanabe , Masaki Otagiri, Toru Maruyama
- Organizer
  米国薬学会 American Association of Pharmaceutical Scientists (AAPS)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18H02604
[Presentation] 瘍微小環境を治療標的とするDual targeting担体の開発と癌DDS治療への応用2018
- Author(s)
  水田　夕稀、前田　仁志、皆吉　勇紀、一水　翔太、木下　遼、異島　優、渡邊　博志、小田切　優樹、丸山　徹
- Organizer
  第35回日本薬学会九州支部大会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] 腫瘍関連マクロファージを標的とした新規DDS担体の開発2018
- Author(s)
  水田　夕稀、前田　仁志、異島　優、皆吉　勇紀、一水　翔太、木下　遼、渡邊　博志、小田切　優樹、丸山　徹
- Organizer
  第34回日本DDS学会学術集会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] 急性腎障害に対する一酸化炭素デリバリーシステムの有用性評価2018
- Author(s)
  永崎　太清、柳澤　洋輝、田口　和明、西田　健人、前田　仁志、酒井　宏水、渡邊　博志、深川　雅史、小田切　優樹、丸山　徹
- Organizer
  第25回日本血液代替物学会
- Data Source
  KAKENHI-PROJECT-18H02604
[Presentation] 腎線維化病態に対するバイオミメティックな一酸化窒素デリバリーシステムの有用性評価2018
- Author(s)
  大城俊、異島優、渡邊博志、前田仁志、深川雅史、小田切優樹、丸山徹
- Organizer
  日本薬剤学会第33年会
- Data Source
  KAKENHI-PROJECT-18H02604
[Presentation] バイオミメティックな一酸化炭素デリバリーは脂肪肝の再生不全を改善する2018
- Author(s)
  和田　直樹、柳澤　洋輝、田口　和明、前田　仁志、木下　学、酒井　宏水、渡邊　博志、小田切　優樹、丸山　徹
- Organizer
  第25回日本血液代替物学会
- Data Source
  KAKENHI-PROJECT-18H02604
[Presentation] 腎臓内脂肪酸の質的変動に着目した新規腎病態メカニズムの解明2017
- Author(s)
  今福匡司、渡邊博志、佐藤崇雄、前田仁志、田中元子、松下和孝、深川雅史、丸山徹
- Organizer
  第59回日本脂質生化学会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] 持続型BMP7誘導体の肝線維化モデルに対する有用性評価2017
- Author(s)
  高野芽依、渡邊博志、前田仁志、小田切優樹、丸山徹
- Organizer
  第34回日本薬学会九州支部大会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] 細胞透過型アルブミンの細胞内薬物送達能に関する有用性評価2017
- Author(s)
  一水翔太, 渡邊博志, 前田仁志, 濱崎慶輔, 異島優, 小田切優樹, 丸山徹
- Organizer
  第33回日本DDS学会学術集会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] 1型インターフェロンのクッパー細胞デリバリーシステムと肝保護効果2017
- Author(s)
  皆吉勇紀、前田仁志、渡邊博志、異島優、小田切優樹、丸山徹
- Organizer
  第24回日本血液代替物学会年次大会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] クッパー細胞標的性1型インターフェロンの抗炎症・免疫調節作用を介した肝保護効果の検討2017
- Author(s)
  皆吉勇紀、前田仁志、異島優、渡邊博志、小田切優樹、丸山徹
- Organizer
  日本薬物動態学会第32回年会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] ヘモグロビンを担体とした新規一酸化炭素デリバリーシステムの非アルコール性脂肪肝炎 (NASH) に対する有用性評価2017
- Author(s)
  柳澤洋輝、前田仁志、皆吉勇紀、田口和明、異島優、渡邊博志、田中基彦、佐々木裕、小田切優樹、丸山徹
- Organizer
  第39回生体膜と薬物の相互作用シンポジウム
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] 酸化ストレス応答による腎臓内脂肪酸代謝異常を起点とした新規腎病態機序の解明2017
- Author(s)
  今福匡司、渡邊博志、佐藤崇雄、前田仁志、田中元子、松下和孝、深川雅史、丸山徹
- Organizer
  第60回日本腎臓学会学術総会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] 難治性肝炎をターゲットにする抗酸化ナノDDS戦略の構築2017
- Author(s)
  前田仁志、異島優、渡邊博志、小田切優樹、丸山徹
- Organizer
  日本薬学会第138年会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] マンノース受容体を標的とするナノ抗酸化剤の開発と急性及び慢性肝疾患への応用2017
- Author(s)
  前田仁志、異島優、渡邊博志、小田切優樹、丸山徹
- Organizer
  第26回DDSカンファランス
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] ヘモグロビンを担体とした一酸化炭素の肝臓デリバリーとNASH病態改善機序2017
- Author(s)
  柳澤洋輝、前田仁志、皆吉勇紀、田口和明、異島優、渡邊博志、田中基彦、佐々木裕、小田切優樹、丸山徹
- Organizer
  第24回日本血液代替物学会年次大会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] チオールと一酸化窒素の肝デュアルデリバリーシステムの構築とNASH治療への応用2017
- Author(s)
  前田仁志、異島優、皆吉勇紀、一水翔太、柳澤洋輝、渡邊博志、小田切優樹、丸山徹
- Organizer
  日本薬剤学会　第32回年会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] 一酸化窒素とチオールを基軸とした新規 NASH 治療法の開発2017
- Author(s)
  前田仁志、異島優、皆吉勇紀、一水翔太、柳澤洋輝、渡邊博志、小田切優樹、丸山徹
- Organizer
  第17回日本NO学会学術集会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] In silico解析へ向けたα1-酸性糖タンパク質異型間の薬物結合選択性に寄与するアミノ酸残基の同定2017
- Author(s)
  中村侑加、渡邊博志、中村照也、池鯉鮒麻美、石躍華奈、前田仁志、山縣ゆり子、小田切優樹、丸山徹
- Organizer
  日本薬学会第138年会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] 腎線維化病態に対する一酸化窒素デリバリーシステムの有用性評価2017
- Author(s)
  大城俊、渡邊博志、前田仁志、田中元子、松下和孝、深川雅史、丸山徹
- Organizer
  第60回日本腎臓学会学術総会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] ヘモグロビンを担体とした一酸化炭素デリバリーシステムの非アルコール性脂肪肝炎 (NASH) に対する有用性評価2017
- Author(s)
  柳澤洋輝、前田仁志、皆吉勇紀、田口和明、異島優、渡邊博志、田中基彦、佐々木裕、小田切優樹、丸山徹
- Organizer
  第34回日本薬学会九州支部大会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] 腎線維化病態に対する一酸化窒素デリバリーシステムの有用性評価2017
- Author(s)
  大城俊、異島優、渡邊博志、前田仁志、田中元子、深川雅史、小田切優樹、　　　　丸山徹
- Organizer
  第34回日本薬学会九州支部大会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] エテルカルセチドの適正使用へ向けたアルブミンとのジスルフィド結合解析2017
- Author(s)
  今福匡司、田中翔馬、田中元子、松下和孝、前田仁志、渡邊博志、小田切優樹、丸山徹
- Organizer
  日本薬学会第138年会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] 副甲状腺ホルモンによるCYP3A発現抑制とその分子機構解明2017
- Author(s)
  池上孝明、渡邊博志、杉本龍星、前田仁志、深川雅史、丸山徹
- Organizer
  第34回日本薬学会九州支部大会
- Data Source
  KAKENHI-PROJECT-17K15511
[Presentation] アルブミン融合技術を基盤としたクッパー細胞指向性Ⅰ型インターフェロンの設計と肝保護効果2017
- Author(s)
  皆吉勇紀、前田仁志、渡邊博志、異島優、小田切優樹、丸山徹
- Organizer
  日本薬剤学会　第32回年会
- Data Source
  KAKENHI-PROJECT-17K15511

1. Maruyama Toru (90423657)

# of Collaborated Projects: 2 results

# of Collaborated Products: 16 results
2. 渡邊博志 (70398220)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
3. WATANABE Hiroshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 16 results
4. INAZUMI Tomoaki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. KADOWAKI Daisuke

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
6. KOGA Tomoaki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. NAKAMURA Teruya

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. KURAUCHI Yuki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. ISHITSUKA Youichi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
10. 杉本幸彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
11. 小田切優樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
12. 田口和明

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. 香月博志

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
14. 榎木裕紀

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

MAEDA HITOSHI 前田 仁志

Hitoshi Maeda 前田 仁志

Research Projects

Research Products

Co-Researchers

癌細胞-癌微小環境ネットワークを狙い撃つ革新的な抗癌剤送達システムの開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of Biomimetic DDS to improve healthy longevity and its application to the treatment for sarcopenia

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a renal carbon monoxide delivery system for treatment of lethal rhabdomyolysis

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of innovative drug delivery carrier targeting tumor microenvironment and application for intractable cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] A Mannosylated, PEGylated Albumin as a Drug Delivery System for the Treatment of Cancer Stroma Cells2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effects of Uremic Toxins on the Binding of Aripiprazole to Human Serum Albumin2021

Author(s)

Journal Title

DOI

NAID

ISSN

Year and Date

Language

Data Source

[Journal Article] A synthetic retinoic acid receptor agonist Am80 ameliorates renal fibrosis via inducing the production of alpha-1-acid glycoprotein2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effect of Cinacalcet on the Redox Status of Albumin in Secondary Hyperparathyroidism Patients Receiving Hemodialysis2020

Author(s)

Journal Title

DOI

NAID

ISSN

Language

Data Source

[Journal Article] The late-stage protective effect of Mito-TEMPO against acetaminophen-induced hepatotoxicity in mouse and three-dimensional cell culture models2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] alfa1-acid glycoprotein attenuates adriamycin-induced nephropathy via CD163 expressing macrophages induction.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A synthetic retinoic acid receptor agonist Am80 ameliorates renal fibrosis via inducing the production of alpha-1-acid glycoprotein.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Indoxyl sulfate contributes to adipose tissue inflammation through the activation of NADPH oxidase2020

Author(s)

Journal Title

DOI

MAEDA HITOSHI 前田仁志

Hitoshi Maeda 前田仁志

[Presentation] Development of a novel tumor microenvironment-targeted drug deliver carrier；TAMとCAFを包括的に標的化する抗がん剤デリバリーシステムの構築2019

[Presentation] 腎線維化病態に対するバイオミメティックな一酸化窒素デリバリーシステムの有用性評価2018